Torrent Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Torrent Pharmaceuticals has a total shareholder equity of ₹67.1B and total debt of ₹44.9B, which brings its debt-to-equity ratio to 66.9%. Its total assets and total liabilities are ₹147.4B and ₹80.4B respectively. Torrent Pharmaceuticals's EBIT is ₹24.2B making its interest coverage ratio 6.6. It has cash and short-term investments of ₹7.9B.
Key information
66.9%
Debt to equity ratio
₹44.89b
Debt
Interest coverage ratio | 6.6x |
Cash | ₹7.90b |
Equity | ₹67.07b |
Total liabilities | ₹80.37b |
Total assets | ₹147.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500420's short term assets (₹52.9B) exceed its short term liabilities (₹49.0B).
Long Term Liabilities: 500420's short term assets (₹52.9B) exceed its long term liabilities (₹31.4B).
Debt to Equity History and Analysis
Debt Level: 500420's net debt to equity ratio (55.2%) is considered high.
Reducing Debt: 500420's debt to equity ratio has reduced from 120.3% to 66.9% over the past 5 years.
Debt Coverage: 500420's debt is well covered by operating cash flow (63.9%).
Interest Coverage: 500420's interest payments on its debt are well covered by EBIT (6.6x coverage).